Atlanta Center for Medical Research

Interested in volunteering for a clinical study? Please fill out the following form so that we may determine your eligibility for one of ACMR’s ongoing or upcoming studies.

At least one way to contact you is required:

Clicking submit will place you on ACMR’s email newsletter list. You may unsubscribe any time.


According to the Lewy Body Dementia Association, Lewy body dementia (LBD) is widely undiagnosed though it affects an estimated 1.4 million individuals in the United States. LBD can closely resemble other more commonly known diseases such as Alzheimer’s and Parkinson’s, and is an umbrella term for two related diagnoses. LBD refers to both Parkinson’s disease dementia and dementia with Lewy bodies. Symptoms manifest in different degrees in each person and may fluctuate as often as moment-to-moment, hour-to-hour, or day-to-day.

The Lewy Body Dementia separates symptoms into the following categories:

  • Central feature
    • Progressive dementia: deficits in attention and executive functions
  • Core features
    • Fluctuating cognition with pronounced variations in attention and alertness
    • Recurrent complex visual hallucinations, typically well formed and detailed
    • Spontaneous features of parkinsonism
  • Suggestive features
    • REM sleep behavior disorder
    • Severe sensitivity to neuroleptics
  • Supportive features
    • Repeated falls and fainting
    • Transient, unexplained loss of consciousness
    • Autonomic dysfunction
    • Hallucinations of other senses, like touch or hearing

LBD is a multi-system disease and typically requires a comprehensive treatment approach that requires a team of physicians from different specialties. Clinical trials for Lewy body dementia are in the very early stages of trying to develop a drug to treat the disease. Further research is needed in order to allow health care professionals to offer a better and more effective treatment for those suffering from LBD.

Watch the video at the link below for more information on Lewy body disease, the importance of clinical trials focusing on LBD, and to see how it affects an individual’s life.

http://www.cbsnews.com/news/experimental-drug-being-tested-for-lewy-body-dementia/

Source: https://www.lbda.org/


The Atlanta Center for Medical Research was founded in 1982 by Dr. Robert A. Riesenberg and is now one of the largest and most respected medical research institutions in the country. ACMR’s 150,000-square-foot, state-of-the-art, open-source research facility is a game changer for the medical research world. ACMR’s practices set the standard for medical research, facilitating the availability of safe and effective medicine to people everywhere.

ACMR uses cookies to collect information on how visitors behave on our website. The information we collect will not be linked with a visitor's identity.
By continuing to use our website, you agree to our use of cookies.